NYSE:EBS - Emergent BioSolutions Inc.
$43.37
 $-0.78
-1.76%
12:35PM EDT
2019-07-22
Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  EBS     avg for
industry  
  avg for
sector  
42 stocks weight:  162. 93   217. 37   399. 45  
42 stocks rank:  1. 33 K 1. 27 K 716. 99  
# analyst opinions:  6. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  1. 04   5. 49   1. 88  
current ratio:  2. 13   5. 87   2. 36  

target price low:  60. 00   83. 44   114. 90  
target price avg:  68. 67   106. 20   137. 90  
target price high:  75. 00   132. 30   158. 97  
1-yr high:  73. 24   111. 86   142. 57  
last close:  44. 15   86. 79   125. 44  
50-day avg:  44. 75   86. 68   122. 63  
200-day avg:  56. 18   89. 22   121. 38  
1-yr low:  39. 92   69. 78   100. 51  
volume:  320. 35 K 2. 62 M 3. 43 M
50-day avg volume:  387. 48 K 3. 20 M 4. 16 M
200-day avg volume:  448. 04 K 2. 99 M 4. 75 M

1-day return:  0. 50 % -1. 30 % -0. 99 %
this week return:  2. 08 % 0. 45 % -0. 20 %
12-wk return:  -17. 43 % 0. 94 % 4. 84 %
52-wk return:  -18. 93 % -1. 30 % 10. 55 %

enterprise value (EV):  2. 89 B 45. 10 B 122. 38 B
market cap:  2. 27 B 38. 96 B 108. 40 B
EBITDA:  168. 80 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  17. 11   5. 38   11. 93  
enterprise/revenue (EV/R):  3. 38   57. 92   10. 21  
total revenue:  855. 20 M 9. 91 B 39. 98 B
total debt:  756. 10 M 10. 90 B 17. 48 B
debt/equity:  76. 57   57. 18   120. 05  
net income (common):  41. 60 M 2. 07 B 4. 05 B

shares outstanding:  51. 38 M 538. 09 M 1. 24 B
shares:  43. 07 M 548. 00 M 1. 22 B
shares short:  3. 83 M 10. 98 M 11. 87 M
shares short prior month:  3. 49 M 9. 32 M 12. 05 M
short ratio:  8. 49   5. 60   3. 34  
short % of float:  10. 45 % 6. 48 % 2. 64 %
total cash/share:  2. 67   10. 98   9. 19  
total cash:  137. 20 M 5. 93 B 6. 10 B
free cash flow:  135. 07 M 2. 92 B 4. 55 B
operating cash flow:  147. 60 M 3. 80 B 5. 78 B

book value:  19. 21   13. 35   27. 45  
price/book:  2. 30   4. 60   8. 78  
gross profits:  317. 30 M 7. 44 B 36. 13 B
operating margins:  10. 86 % -308. 40 % -28. 55 %
EBITDA margins:  19. 74 % 13. 17 % 23. 38 %
profit margins:  4. 86 % 10. 44 % 14. 18 %
gross margins:  39. 24 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  0. 80   2. 10   4. 23  
forward EPS:  3. 27   3. 45   7. 10  
P/E:  55. 05   1. 90   32. 10  
forward P/E:  13. 50   6. 46   15. 47  
PE/G:  0. 89   0. 70   -0. 54  
growth:  61. 80 % 265. 63 % 79. 11 %
earnings high:  0. 47   0. 89   1. 68  
earnings avg:  0. 17   0. 70   1. 57  
earnings low:  -0. 07   0. 46   1. 46  
revenue high:  218. 50 M 2. 57 B 11. 07 B
revenue avg:  212. 06 M 2. 51 B 10. 91 B
revenue low:  200. 70 M 2. 45 B 10. 73 B
return on assets:  3. 60 % -2. 34 % 5. 28 %
return on equity:  4. 45 % -90. 08 % 133. 53 %
revenue growth:  61. 80 % 265. 25 % 73. 68 %
revenue/share:  16. 93   12. 72   60. 04  

beta (1yr vs S&P500):  1. 11   1. 27   0. 91  
sharpe (1yr):  -0. 36   0. 16   0. 77  

held % insiders:  14. 90 % 6. 06 % 3. 29 %
held % institutions:  85. 39 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : EBS
.    145.337 =       145.337 :: --> INITIAL WEIGHT <--
.    + 0.802 =       146.139 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 0.928 =       135.625 :: P/E factor
.    x 1.029 =       139.604 :: PE/G factor
.    x 1.705 =       237.973 :: beta factor
.    x 0.769 =       183.008 :: sharpe factor
.    x 2.363 =       432.384 :: current ratio factor
.    x 2.266 =       979.611 :: quick ratio factor
.    x 1.057 =      1035.697 :: short ratio factor
.    x 1.087 =      1125.522 :: return on assets factor
.    x 1.113 =      1252.473 :: return on equity factor
.    x 1.885 =      2360.995 :: revenue growth factor
.    x 1.058 =      2498.642 :: EV/R factor
.    x 1.011 =      2527.189 :: price-to-book factor
.    x 1.104 =      2790.164 :: EBITDA factor
.    x 1.527 =      4261.367 :: EBITDA vs industry factor
.    x 1.131 =      4819.893 :: debt-to-revenue factor
.    x 1.289 =      6211.861 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     13174.072 :: sector+industry 1-year gains factor
.    x 1.009 =     13298.278 :: industry 12-weeks return factor
.    x 1.308 =     17392.666 :: industry 2-weeks return factor
.    x 0.958 =     16664.868 :: company one-year gains+dividend factor
.    x 2.185 =     36405.939 :: company 13 weeks' performance factor
.    x 0.985 =     35865.763 :: "drift" penalty 3 days ago
.    x 0.994 =     35633.522 :: "drift" penalty 4 days ago
.    / 1.863 =     19125.464 :: overall "drift" factor
.    x 0.892 =     17055.186 :: largest single-day jump factor
.        x 1 =     17055.186 :: volatility factor
.        x 1 =     17055.186 :: 42-day volatility factor
.    x 2.906 =      49562.07 :: notable returns + performance factor
.    x 3.467 =    171839.298 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.326 =     227842.04 :: forward EPS factor
.    x 1.629 =    371075.553 :: forward P/E factor
.    x 1.185 =    439617.846 :: industry recommendation factor
.    x 2.176 =    956643.174 :: company recommendation factor
.    x 1.003 =     959288.66 :: factor historical industry gain for week 29
.    x 1.743 =   1672423.355 :: target low factor
.    x 1.248 =   2087874.393 :: target mean factor
.    x 1.035 =   2161176.404 :: target high factor
.   x 10.766 =  23266845.441 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        69.452 :: reduced for readability
.   + 81.069 =       150.521 :: add/subtract for investor sentiment
.   + 12.411 =       162.932 :: earnings report in 11 days
.                               --> FINAL WEIGHT <--
.                    162.932 :: FINAL WEIGHT for NYSE:EBS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org